[1]
Rebaz M. Ali et al. 2025. Pembrolizumab and Sarcoma: A meta-analysis. Judi Clinical Journal. 1, 1 (Jun. 2025), 51–62. DOI:https://doi.org/10.70955/JCJ.2025.6.